Fiche centre
Shanghai Chest hospital
Shanghai — China
Essais liés12clinical trials
VilleShanghailocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07830095
Essais cliniques associés
12| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Pulsed Field Ablation System and Single-Use Pulsed Field Ablation Catheter | Cancer | Non applicable | NCT07889297 | Pulsed Field Ablation for the Treatment of Malignant Lung Tumors | NOT_YET_RECRUITING |
| Ipatasertib | Cancer | Phase 3 | NCT05862285 | UmbrellaMAX — A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study | RECRUITING |
| BMS-986504 | Cancer | Phase 2/3 | NCT07063745 | MountainTAP-29 — A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion | RECRUITING |
| Nivolumab | Cancer | Phase 3 | NCT06561386 | RELATIVITY1093 — A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% | RECRUITING |
| Finerenone | Insuffisance cardiaque | Phase 3 | NCT07575672 | FINE-VALUE — Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure | RECRUITING |
| Pulmonary Radiofrequency Ablation System and the Disposable Pulmonary Radiofrequency Ablation Catheter | Cancer | Non applicable | NCT04619472 | BRONC-RFⅡ — Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors | COMPLETED |
| PF-08634404 | Cancer | Phase 2 | NCT07476287 | Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer | RECRUITING |
| 5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation | Cancer | Non applicable | NCT07830095 | 5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for Pulmonary Malignancies | NOT_YET_RECRUITING |
| C-CAR031 | SEP | Phase 1 | NCT07444281 | An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer | RECRUITING |
| Amivantamab | Cancer | Phase 3 | NCT04538664 | PAPILLON — A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions | ACTIVE_NOT_RECRUITING |
| Adagrasib | Cancer | Phase 3 | NCT06875310 | A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) | RECRUITING |
| Furmonertinib 160mg | Cancer | Phase 1 | NCT04858958 | FAVOUR — Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation | COMPLETED |